Yoo Juyoung, Song Jason Jungsik, Park Yong-Beom, Lee Sang-Won
Division of Rheumatology, Department of Internal Medicine, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Republic of Korea.
Institute for Immunology and Immunological Diseases, Yonsei University College of Medicine, Seoul, Republic of Korea.
Clin Rheumatol. 2020 Oct;39(10):3009-3015. doi: 10.1007/s10067-020-05104-5. Epub 2020 May 4.
Serum IgG4 may often increases in allergic diseases. Eosinophilic granulomatosis with polyangiitis (EGPA) has an allergic phase. For this reason, it was questionable whether IgG4-RD and EGPA may share some clinical and laboratory features. In this study, we investigated whether definite IgG4-RD might share those features with EGPA.
We retrospectively reviewed the medical records of 42 Korean immunosuppressive drug-naïve patients with definite IgG4-RD. The American College of Rheumatology 1990 criteria for classification (the 1990 ACR criteria) for Churg-Strauss syndrome (CSS, known as EGPA) were applied to patients who were previously diagnosed with definite IgG4-RD and had no antineutrophil cytoplasmic antibody (ANCA). Definite IgG4-RD was defined when 3 components of the comprehensive diagnostic criteria were met.
The median age of 42 patients was 61.0 years and 69% of them were men. The median serum IgG4 level was 379.0 mg/dL and the median IgG4+/IgG+ cells ratio was 50.0%. The most common biopsy site was the salivary gland (14.3%). Antinuclear antibody was detected in 6 patients, and test results for ANCA were negative in all patients. Among 42 patients with definite IgG4-RD without ANCA, none of them met the 1990 ACR classification criteria for EGPA.
Definite IgG4-RD found to have no overlap with EGPA when the 1990 ACR criteria for CCS were applied to Korean patients. Key Points • None of 42 Korean patients with definite IgG4-RD without ANCA met the 1990 ACR classification criteria for EGPA. • Definite IgG4-RD found to have no overlap with EGPA in Korean patients without ANCA.
血清IgG4在过敏性疾病中常升高。嗜酸性肉芽肿性多血管炎(EGPA)有过敏期。因此,IgG4相关性疾病(IgG4-RD)与EGPA是否可能有一些临床和实验室特征存在疑问。在本研究中,我们调查了确诊的IgG4-RD是否与EGPA有这些共同特征。
我们回顾性分析了42例未使用免疫抑制药物的韩国确诊IgG4-RD患者的病历。美国风湿病学会1990年的Churg-Strauss综合征(CSS,即EGPA)分类标准应用于先前诊断为确诊IgG4-RD且无抗中性粒细胞胞浆抗体(ANCA)的患者。当满足综合诊断标准的3项指标时定义为确诊IgG4-RD。
42例患者的中位年龄为61.0岁,其中69%为男性。血清IgG4水平中位数为379.0mg/dL,IgG4+/IgG+细胞比例中位数为50.0%。最常见的活检部位是唾液腺(14.3%)。6例患者检测到抗核抗体,所有患者ANCA检测结果均为阴性。在42例无ANCA的确诊IgG4-RD患者中,无一例符合1990年美国风湿病学会EGPA分类标准。
当将1990年美国风湿病学会CSS标准应用于韩国患者时,确诊的IgG4-RD与EGPA无重叠。要点 • 42例无ANCA的韩国确诊IgG4-RD患者中,无一例符合1990年美国风湿病学会EGPA分类标准。 • 在无ANCA的韩国患者中,确诊的IgG4-RD与EGPA无重叠。